Início › Leucemia Linfoblástica Aguda › Califórnia › Baldwin Park
Ensaios clínicos de Leucemia Linfoblástica Aguda em Baldwin Park, CA
21 estudos para Leucemia Linfoblástica Aguda estão buscando participantes em locais em Baldwin Park e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RecrutandoFase 1
- City of Hope, Duarte · a 4 mi de distância
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RecrutandoFase 2
- City of Hope, Duarte · a 4 mi de distância
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
RecrutandoFase 2
- City of Hope Cancer Center (Data collection AND Specimen Analysis), Duarte · a 4 mi de distância
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
RecrutandoFase 1
- City of Hope Medical Center, Duarte · a 4 mi de distância
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
RecrutandoFase 1Voluntários saudáveis bem-vindos
- City of Hope Medical Center, Duarte · a 4 mi de distância
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
RecrutandoFase 1/2
- Research Site, Duarte · a 4 mi de distância
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecrutandoEstudo observacional
- City of Hope, Duarte · a 4 mi de distância
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
RecrutandoFase 2
- City of Hope Medical Center, Duarte · a 4 mi de distância
A Study of Revumenib and Mezigdomide in People With Leukemia
RecrutandoFase 1/2
- City of Hope Cancer Center (Data collection only), Duarte · a 4 mi de distância
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecrutandoEstudo observacional
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi de distância
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
RecrutandoFase 3
- Ascentage Investigative Site #1062, Duarte · a 4 mi de distância
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
RecrutandoFase 1Voluntários saudáveis bem-vindos
- City of Hope Medical Center, Duarte · a 4 mi de distância
Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
RecrutandoFase 1 inicial
- City of Hope Medical Center, Duarte · a 4 mi de distância
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RecrutandoFase 2
- City of Hope, Duarte · a 4 mi de distância
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
RecrutandoFase 2
- City of Hope Medical Center, Duarte · a 4 mi de distância
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
RecrutandoFase 2Voluntários saudáveis bem-vindos
- City of Hope Medical Center, Duarte · a 4 mi de distância
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
RecrutandoFase 1
- City of Hope Medical Center, Duarte · a 4 mi de distância
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
RecrutandoFase 2
- City of Hope Medical Center, Duarte · a 4 mi de distância
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
RecrutandoFase 1
- City of Hope, Duarte · a 4 mi de distância
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
RecrutandoFase 2
- City of Hope Medical Center, Duarte · a 4 mi de distância
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RecrutandoFase 1
- City of Hope, Duarte · a 4 mi de distância
Ensaios de Leucemia Linfoblástica Aguda em outras cidades
- Houston, TX28 estudos
- New York City, NY24 estudos
- Seattle, WA21 estudos
- Chicago, IL19 estudos
- Atlanta, GA19 estudos
- Philadelphia, PA16 estudos
- Memphis, TN16 estudos
- Washington, DC16 estudos
- Boston, MA15 estudos
- Los Angeles, CA14 estudos
- Durham, NC13 estudos
- Mountain View, CA13 estudos
Outros estudos em Baldwin Park
- Câncer de Mama45 estudos
- Leucemia Mieloide Aguda40 estudos
- Câncer Colorretal38 estudos
- Câncer de Pulmão de Não Pequenas Células36 estudos
- Câncer (todos os tipos)33 estudos
- Câncer de Próstata30 estudos
- Câncer Metastático30 estudos
- Síndromes Mielodisplásicas26 estudos
- Câncer de Ovário25 estudos
- Câncer de Pulmão24 estudos
- Mieloma Múltiplo23 estudos
- Câncer de Estômago22 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.